Effects of geldanamycin on imatinib mesylate sensitive and resistant Ph plus pediatric acute lymphoblastic leukemia

被引：0
|
作者：
Jayanthan, AA [1 ]
Hawkins, LM [1 ]
Narendran, A [1 ]
机构：
[1] Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3283
引用
收藏
页码：882A / 883A
页数：2
相关论文
共 50 条
  • [1] THE DYNAMICS OF ABL MUTATIONS ONSET IN PH plus ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH IMATINIB MESYLATE
    Peluso, A. L.
    Grammatico, S.
    Elia, L.
    Izzo, B.
    Muccioli-Casadei, G.
    Vitale, D.
    Andreozzi, M. C.
    Esposito, N.
    Picardi, M.
    Martinelli, G.
    Poverini, S.
    Cimino, G.
    Pane, F.
    HAEMATOLOGICA, 2008, 93 : S87 - S87
  • [2] The study of resistant mechanisms and reversal in an imatinib resistant Ph plus acute lymphoblastic leukemia cell line
    Xing, Hongyun
    Yang, Xi
    Liu, Ting
    Lin, Juan
    Chen, Xiaoyi
    Gong, Yuping
    LEUKEMIA RESEARCH, 2012, 36 (04) : 509 - 513
  • [3] To Study Resistant Mechanisms and Reversal In An Imatinib Resistant Ph plus Positive Acute Lymphoblastic Leukemia Cell Line.
    Xing, Hongyun
    Gong, Yuping
    Liu, Ting
    BLOOD, 2010, 116 (21) : 882 - 882
  • [4] Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph plus acute lymphoblastic leukemia
    Visani, G.
    Piccaluga, P.
    Malagola, M.
    Isidori, A.
    LEUKEMIA, 2009, 23 (09) : 1687 - 1688
  • [5] Nilotinib monotherapy in patients with imatinib-resistant or -intolerant PH plus chronic myelogenous leukemia in blast crisis or relapsed/refractory PH plus acute lymphoblastic leukemia
    Ottmann, O.
    Larson, R.
    Kantarjian, H.
    Le Coutre, P.
    Baccarani, M.
    Weitzman, A.
    Giles, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 207 - 207
  • [6] Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate
    Ribera, JM
    Oriol, A
    Gonzalez, M
    Vidriales, MB
    Xicoy, B
    Grau, J
    Esteve, J
    Brunet, S
    Del Potro, E
    Moreno, MJ
    Tormo, M
    Martin-Reina, MV
    Deben, G
    Parody, R
    Lahuerta, UJ
    San Miguel, JF
    BLOOD, 2004, 104 (11) : 203B - 204B
  • [7] Imatinib for secondary Ph plus acute lymphoblastic leukemia induces response in concomitant GBM
    De Vita, S
    De Matteis, S
    Laurenti, L
    Chiusolo, P
    Sorà, F
    Piccirillo, N
    Reddiconto, G
    Fiorini, A
    Leone, G
    Sica, S
    ANNALS OF ONCOLOGY, 2006, 17 (04)
  • [8] Huaier Extract Enhances the Treatment Efficacy of Imatinib in Ph plus Acute Lymphoblastic Leukemia
    Zhou, F.
    Ping, Q.
    Juan, H.
    Runming, J.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S171 - S171
  • [9] Anterior chamber infiltration in a patient with Ph plus acute lymphoblastic leukemia in remission with imatinib
    Hurtado-Sarrió, M
    Duch-Samper, A
    Taboada-Esteve, J
    Martínez-Dominguez, JA
    Senent-Peris, ML
    Menezo-Rozalén, JL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (04) : 723 - 724
  • [10] Phase II trial demonstrates imatinib efficacy for Ph plus acute lymphoblastic leukemia
    不详
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (06) : 615 - 615
12345